GI (RTOG 0848): Resected Head of Pancreas Treatment with Chemotherapy and Radiation
A Phase III Trial Evaluating Both Erlotinib and Chemoradiation as Adjuvant Treatment for Patients with Resected Head of Pancreas Adenocarcinoma
T1-3, N0-1, M0. Surgery with potentially curative intent (removal of entire tumor) using a "Whipple" procedure or a pylorus preserving pancreatidicoduodenectomy. Must not be managed with a pancreatectomy, distal pancreatectomy or central pancreatectomy. Must be able to maintain >/= 1,500 calories per day.